Centice Adds 14 New Synthetic Drugs to Illicit Drug Identification Library
New drugs help law enforcement identify opioids, synthetic cannabinoids, and bath salt mixtures in the field
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Centice Corporation, a pioneer in chemical verification and identification using Raman spectroscopy and computational sensor technology, today announced the addition of 14 new drugs to their narcotic library. The new drugs include Fentanyl (a synthetic opioid), synthetic phenethylamines (psychotic stimulants), cathinones (used in making bath salts), and synthetic cannabinoids (used to manufacture synthetic marijuana commonly referred to as “spice”). The new drugs will be available immediately.
“Centice is committed to delivering the highest standard of drug identification technology”
One of the biggest trends is toward synthetic or “designer” drugs, including amphetamine-type substances, “bath salts”, and synthetic cannabinoids (“spice”). These cannabinoids are often seen in so-called “fake pot” products that are falsely marketed and sold as “herbal incense” or “potpourri”. Their widely ranging chemical compositions make it challenging for the law to keep up with new variants, both in terms of legislation and identification.
Centice’s MFL-3000 enables law enforcement, narcotic squads, and drug task forces to quickly and easily perform drug identification in the field without destroying any evidence. Centice’s Raman spectroscopy technology rapidly scans any pill or illicit substance and identifies its unique spectral fingerprint and compares it to a library of substances. With a library of over 3,600 narcotics, precursors, synthetic drugs, and prescription pills, the MFL-3000 helps law enforcement identify the vast majority of illicit substances found on the street. In addition to illegal drugs and prescription pills, the MFL-3000 also identifies cutting agents and precursors used in making illicit drugs, and works with both pure substances and mixtures.
“Centice is committed to delivering the highest standard of drug identification technology,” said John Goehrke, CEO of Centice. “We constantly monitor new drugs that enter the market, both domestically and abroad. By working with our customers, law enforcement and federal agencies we are committed to delivering the most accurate and complete library for substance identification.”
Raman spectroscopy adapts particularly well to the challenge of emerging drugs. Each compound or mixture scanned has a unique spectral fingerprint that can be added to the library as it is encountered, allowing comparison to another unknown substance within minutes. This type of detailed comparison can be used to identify drugs by batch, and to link distribution. Combined with the ability to identify precursors and essential chemicals, Raman offers first responders the kind of forensic intelligence needed to act quickly and decisively.
To schedule a demo or hear from law enforcement professionals using MFL-3000, visit www.centice.com.
Centice Corporation is a leader in delivering unique technology and systems for identification and verification of chemical substances. The MFL-3000, which uses Centice’s patented coded aperture Raman Spectroscopy technology, allows law enforcement agencies to quickly identify over 3,600 Controlled Prescription Drugs (CPD), street narcotics and cutting agent mixtures. The portable system provides field narcotic officers and drug interdiction agents with technology typically only available to crime labs. Operating worldwide through a network of distributors and support organizations the company sells to governments, non-governmental organizations (NGO), and local law enforcement departments. By leveraging expertise in applied Raman Spectroscopy and patented Coded Aperture design our engineers deliver on faster acquisition times, greater sensor reliability, and more sensitive spectra data acquisition. The company is headquartered in Morrisville, NC was founded in 2004 from technology created at Duke University.